Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Parniak

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Biochemistry|February 3, 2005
Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activitiesCathryn A Shaw-Reid, Bradley Feuston, Vandna Munshi, et al.
Antimicrobial Agents and Chemotherapy|June 21, 2012
Response of simian immunodeficiency virus to the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine in vitro and in vivoMichael Murphey-Corb, Premeela Rajakumar, Heather Michael, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|November 22, 2012
The anti-HIV microbicide candidate RC-101 inhibits pathogenic vaginal bacteria without harming endogenous flora or mucosaColleen R Eade, Amy L Cole, Camila Diaz, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2021
Development of Human Immunodeficiency Virus Type 1 Resistance to 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine Starting with Wild-Type or Nucleoside Reverse Transcriptase Inhibitor-Resistant StrainsMaria E Cilento, Aaron B Reeve, Eleftherios Michailidis, et al.
European Journal of Medicinal Chemistry|April 7, 2017
Synthesis, biological evaluation and molecular modeling of 2-Hydroxyisoquinoline-1,3-dione analogues as inhibitors of HIV reverse transcriptase associated ribonuclease H and polymeraseJing Tang, Sanjeev Kumar V Vernekar, Yue-Lei Chen, et al.
Structure (London, England : 1993)|September 1, 2019
Conformational Changes in HIV-1 Reverse Transcriptase that Facilitate Its MaturationRyan L Slack, Tatiana V Ilina, Zhaoyong Xi, et al.
Biomolecules|July 27, 2024
Discovery of Benzisothiazolone Derivatives as Bifunctional Inhibitors of HIV-1 Reverse Transcriptase DNA Polymerase and Ribonuclease H ActivitiesAlondra Vázquez Rivera, Heather Donald, Mounia Alaoui-El-Azher, et al.
Journal of Medicinal Chemistry|March 2, 2016
3-Hydroxypyrimidine-2,4-diones as Selective Active Site Inhibitors of HIV Reverse Transcriptase-Associated RNase H: Design, Synthesis, and Biochemical EvaluationsJing Tang, Feng Liu, Eva Nagy, et al.
The Journal of Organic Chemistry|February 28, 2015
Synthesis and properties of 2'-deoxy-2',4'-difluoroarabinose-modified nucleic acidsSaúl Martínez-Montero, Glen F Deleavey, Arden Dierker-Viik, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2016
Structural basis of HIV inhibition by translocation-defective RT inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA)Zhe Li Salie, Karen A Kirby, Eleftherios Michailidis, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Biochemistry|February 3, 2005
Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activitiesCathryn A Shaw-Reid, Bradley Feuston, Vandna Munshi, et al.
Antimicrobial Agents and Chemotherapy|June 21, 2012
Response of simian immunodeficiency virus to the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine in vitro and in vivoMichael Murphey-Corb, Premeela Rajakumar, Heather Michael, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|November 22, 2012
The anti-HIV microbicide candidate RC-101 inhibits pathogenic vaginal bacteria without harming endogenous flora or mucosaColleen R Eade, Amy L Cole, Camila Diaz, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2021
Development of Human Immunodeficiency Virus Type 1 Resistance to 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine Starting with Wild-Type or Nucleoside Reverse Transcriptase Inhibitor-Resistant StrainsMaria E Cilento, Aaron B Reeve, Eleftherios Michailidis, et al.
European Journal of Medicinal Chemistry|April 7, 2017
Synthesis, biological evaluation and molecular modeling of 2-Hydroxyisoquinoline-1,3-dione analogues as inhibitors of HIV reverse transcriptase associated ribonuclease H and polymeraseJing Tang, Sanjeev Kumar V Vernekar, Yue-Lei Chen, et al.
Structure (London, England : 1993)|September 1, 2019
Conformational Changes in HIV-1 Reverse Transcriptase that Facilitate Its MaturationRyan L Slack, Tatiana V Ilina, Zhaoyong Xi, et al.
Biomolecules|July 27, 2024
Discovery of Benzisothiazolone Derivatives as Bifunctional Inhibitors of HIV-1 Reverse Transcriptase DNA Polymerase and Ribonuclease H ActivitiesAlondra Vázquez Rivera, Heather Donald, Mounia Alaoui-El-Azher, et al.
Journal of Medicinal Chemistry|March 2, 2016
3-Hydroxypyrimidine-2,4-diones as Selective Active Site Inhibitors of HIV Reverse Transcriptase-Associated RNase H: Design, Synthesis, and Biochemical EvaluationsJing Tang, Feng Liu, Eva Nagy, et al.
The Journal of Organic Chemistry|February 28, 2015
Synthesis and properties of 2'-deoxy-2',4'-difluoroarabinose-modified nucleic acidsSaúl Martínez-Montero, Glen F Deleavey, Arden Dierker-Viik, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2016
Structural basis of HIV inhibition by translocation-defective RT inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA)Zhe Li Salie, Karen A Kirby, Eleftherios Michailidis, et al.
Pageof 9